4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-021993
Chief Operating Officer gave up 2,990 shares (to pay taxes)
- Chief Operating Officer acquired 6,863 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cittadine Andrew · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-30 | Exercise or conversion : show line 1 in the form | +6,863 | 48,848 | D | ||
| 2025-06-30 | Shares withheld for taxes : show line 2 in the form | −2,990 | $35.78 | $106,982 | 45,858 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −6,863 | 43,001 | D |
Loading xslF345X05/rdgdoc.xml…